- Home
- WKSP vs IPA Comparison
WKSP vs IPA Comparison
Compare WKSP & IPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WKSP
- IPA
- Stock Information
- Founded
- WKSP 2003
- IPA 1983
- Country
- WKSP United States
- IPA Canada
- Employees
- WKSP N/A
- IPA N/A
- Industry
- WKSP Auto Parts:O.E.M.
- IPA Biotechnology: Pharmaceutical Preparations
- Sector
- WKSP Consumer Discretionary
- IPA Health Care
- Exchange
- WKSP Nasdaq
- IPA Nasdaq
- Market Cap
- WKSP 21.3M
- IPA 18.9M
- IPO Year
- WKSP N/A
- IPA 2017
- Fundamental
- Price
- WKSP $0.67
- IPA $0.44
- Analyst Decision
- WKSP
- IPA Strong Buy
- Analyst Count
- WKSP 0
- IPA 2
- Target Price
- WKSP N/A
- IPA $6.00
- AVG Volume (30 Days)
- WKSP 919.5K
- IPA 1.1M
- Earning Date
- WKSP 11-13-2024
- IPA 12-12-2024
- Dividend Yield
- WKSP N/A
- IPA N/A
- EPS Growth
- WKSP N/A
- IPA N/A
- EPS
- WKSP N/A
- IPA N/A
- Revenue
- WKSP $6,395,908.00
- IPA $17,441,886.00
- Revenue This Year
- WKSP $366.78
- IPA $4.33
- Revenue Next Year
- WKSP $311.43
- IPA $35.64
- P/E Ratio
- WKSP N/A
- IPA N/A
- Revenue Growth
- WKSP 776.97
- IPA 11.21
- 52 Week Low
- WKSP $0.36
- IPA $0.35
- 52 Week High
- WKSP $1.97
- IPA $2.60
- Technical
- Relative Strength Index (RSI)
- WKSP 46.98
- IPA 40.98
- Support Level
- WKSP $0.65
- IPA $0.40
- Resistance Level
- WKSP $0.94
- IPA $0.53
- Average True Range (ATR)
- WKSP 0.09
- IPA 0.07
- MACD
- WKSP -0.01
- IPA 0.00
- Stochastic Oscillator
- WKSP 8.12
- IPA 37.76
About WKSP Worksport Ltd.
Worksport Ltd through its subsidiaries, designs, develops, manufactures, and owns the IP on a variety of tonneau covers, solar integrations, and NP (Non-Parasitic), Hydrogen-based true green energy solutions for the sustainable, clean energy, and automotive industries. The company's product includes soft vinyl tonneau covers and hard aluminum tonneau covers.
About IPA ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies Ltd is a supplier of custom antibodies to the research industry and industrial community. The company has aggregated its operations into one reportable segment, Antibody Production, and Related Services. It operates in three principal geographical areas - the United States of America, Canada, Europe, Australia and others. The majority of its revenue is derived from United States of America.